Fortis Healthcare Ltd. (FORTIS) 52 Week Low Streak Deepens on Second Straight Session

Fortis Healthcare Ltd. has now set a fresh 52-week low for its second straight session, with the streak down 1.72% across the two-day run and the latest trough at Rs 742.6 against a latest traded price of Rs 744.5. Fortis Healthcare Ltd. 52 Week Low Streak confirms a repeated one-year low pattern, but the available market data does not establish any company-specific cause for the continued decline.

With a market capitalisation of Rs 57,188.08 crore, the repeated low matters more than a single-day breakdown because it shows that the stock has stayed below its prior one-year floor across successive sessions. For readers tracking Fortis Healthcare Ltd. 52 Week Low Streak, the key question is not just where the share price traded today, but how the extended streak has altered valuation, sector positioning and peer standing.

Fortis Healthcare Ltd. (FORTIS) 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 744.5
Previous Close	Rs 756
Today's Move	Rs -11.5 (-1.52%)
Open	Rs 759.5
High	Rs 759.5
Low	Rs 742.6
Market Capitalisation	Rs 57,188.08 crore

Fortis Healthcare Ltd. (FORTIS) traded at Rs 744.5 versus the previous close of Rs 756, a fall of 1.52%. The stock opened at Rs 759.5, reached a high of Rs 759.5, touched a low of Rs 742.6.

Fortis Healthcare Ltd. was trading at Rs 744.5 at the article timestamp, lower than the previous close of Rs 756 by Rs 11.5, or 1.52%. The session opened at Rs 759.5, matched the day’s high at Rs 759.5, and slipped to an intraday low of Rs 742.6, which is also the fresh 52-week low for the day. That means the latest traded price was sitting just above the low and well below the opening level, reinforcing the weakness that has marked this Fortis Healthcare Ltd. 52 Week Low Streak.

The price action is notable because the stock did not recover to the open after the first move lower. Instead, it spent the session below the opening print and near the day’s trough, leaving Fortis Healthcare Ltd. 52 Week Low Streak with another lower reference point. The market capitalisation of Rs 57,188.08 crore places the company well above the median market capitalisation in its industry set, but the repeated low pattern shows that size alone has not prevented the decline. For a reader following Fortis Healthcare Ltd. 52 Week Low Streak, the day’s range and the latest traded price both matter, yet they are only the session-level backdrop to the bigger multi-session slide.

What the Repeated 52-Week Lows Show

Fortis Healthcare Ltd. 52 Week Low Streak now covers two consecutive trading sessions, and the cumulative move of -1.72% is the main read-through for the pattern. The stock has not merely revisited a one-year low once; it has reset that low again on the next session, which is a more persistent breakdown than a single-day breach. Because the stock has now printed a fresh 52-week low on back-to-back sessions, the streak itself becomes the key market event.

What the pattern does not show is a verified trigger. Fortis Healthcare Ltd. 52 Week Low Streak tells readers that the share price has continued to trade lower across consecutive sessions, but the market data available here does not identify a company-specific catalyst. That distinction matters, because the repeated one-year low is confirmed numerically while the reason for it remains unconfirmed. For investors tracking Fortis Healthcare Ltd. 52 Week Low Streak, the immediate takeaway is simply that the stock keeps setting lower reference points, and the decline has not yet stabilised within the observed streak.

Fortis Healthcare Ltd. (FORTIS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 57,188.08 crore
P/E Ratio	54.47x
P/B Ratio	5.62x
ROE	11.32%
ROCE	14.07%
EPS	Rs 13.88
Book Value Per Share	Rs 134.61
Dividend Yield	0.13%

Fortis Healthcare Ltd. (FORTIS) fundamental metrics show P/E 54.47x, P/B 5.62x, ROE 11.32%, ROCE 14.07%. Read together, these ratios describe the company's position rather than a recommendation.

Fortis Healthcare Ltd. has a market capitalisation of Rs 57,188.08 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 54.47x, P/B at 5.62x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.32% and ROCE of 14.07%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 13.88, book value per share of Rs 134.61, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 42.33x, median ROE of 13.01%, median ROCE of 15.84%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	54.47x
Benchmark Median P/E	42.33x
Benchmark Average P/E	93.65x
Benchmark P/E Range	6.82x to 1,502.88x
Company P/B Ratio	5.62x
Benchmark Median P/B	3.71x
Company ROE	11.32%
Benchmark Median ROE	13.01%
Company ROCE	14.07%
Benchmark Median ROCE	15.84%
Company Market Capitalisation	Rs 57,188.08 crore
Benchmark Median Market Cap	Rs 447.43 crore

Fortis Healthcare Ltd. (FORTIS) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 54.47x, which is above the benchmark median of 42.33x, a difference of +28.68%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Fortis Healthcare Ltd. (FORTIS) has a ROE of 11.32%, which is below the benchmark median of 13.01%, a difference of -12.99%. Fortis Healthcare Ltd. (FORTIS) has a ROCE of 14.07%, which is below the benchmark median of 15.84%, a difference of -11.17%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Aster DM Healthcare Ltd.	ASTERDM	59,426.27	188.46	14.2	13.07	16.22
Max Healthcare Institute Ltd.	MAXHEALTH	84,580.66	57.68	7.69	14.53	14.97
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	89,254.92	98.46	5.29	12.95	13.93
Global Health Ltd.	MEDANTA	35,176.89	61.94	8.38	15.12	19.38
Narayana Hrudayalaya Ltd.	NH	34,642.22	42.23	7.26	19.86	16.2

Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 54.47x compared with the displayed peer median of 61.94x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 11.32% compares with a peer median of 14.53% across the companies shown in the table. ROCE stood at 14.07% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Fortis Healthcare Ltd. (FORTIS) has a market capitalisation of Rs 57,188.08 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Fortis Healthcare Ltd.

• Fortis Healthcare Ltd. 52 Week Low Streak has now extended to a second straight session, making the repeated low pattern the main price event.
• The cumulative move across the streak is -1.72%, which is the cleanest summary of the decline so far.
• The latest 52-week low of Rs 742.6 is lower than the latest traded price, keeping the stock near its trough.
• Fortis Healthcare Ltd. still trades above the sector median on P/E and P/B, so valuation remains central to the discussion.
• Readers will likely watch whether the next session confirms more back-to-back lows or interrupts the streak.

About Fortis Healthcare Ltd.

Fortis Healthcare Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. For readers following Fortis Healthcare Ltd. 52 Week Low Streak, the relevant business context is that the company is a listed hospital and healthcare services provider whose market value, earnings base and return ratios are being re-judged through a period of repeated one-year lows.

The stock’s current market capitalisation is Rs 57,188.08 crore, which places it well above the industry median in the set shown. That makes the streak more notable as a valuation and sentiment event than as a size issue. Fortis Healthcare Ltd. 52 Week Low Streak is therefore best understood as a price pattern unfolding inside a large listed healthcare business with established revenue and earnings metrics already reflected in the figures above.

Track Fortis Healthcare Ltd. Share Price on Univest

Use Fortis Healthcare Ltd. (FORTIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Fortis Healthcare Ltd. 52 Week Low Streak can be followed alongside the latest traded price, valuation ratios and sector comparison on the company’s share price page. Readers tracking the stock can use the same page to watch whether the repeated one-year low is extended or interrupted in the next session.

Frequently Asked Questions

What is the latest 52-week low for Fortis Healthcare Ltd.?

Ans. The latest 52-week low for Fortis Healthcare Ltd. is Rs 742.6. The latest traded price was Rs 744.5, which remained close to that trough during the session. The stock moved -1.52% during the session.

How does the stock look on valuation after the streak?

Ans. Fortis Healthcare Ltd. trades at a P/E of 54.47 and a P/B of 5.62.

How does Fortis Healthcare Ltd. compare with the healthcare sector?

Ans. Fortis Healthcare Ltd. 52 Week Low Streak leaves the company above the sector median on both P/E and P/B.

Which peer should investors compare it with?

Ans. Peers such as Max Healthcare Institute Ltd., Apollo Hospitals Enterprise Ltd. and Narayana Hrudayalaya Ltd. help show where Fortis sits on valuation and returns within the same industry. Comparable listed companies include Aster DM Healthcare Ltd., Max Healthcare Institute Ltd..

Does the streak mean the company is lower-valued than peers?

Ans. Not automatically. Fortis Healthcare Ltd. 52 Week Low Streak has reduced the share price, but the stock still trades at a premium to the industry median on earnings and book-value multiples.